BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 315.8 SEK 0.13% Market Closed
Market Cap: 27.9B SEK

Wall Street
Price Targets

BIOA B Price Targets Summary
BioArctic AB

There are no price targets for BIOA B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioArctic AB Competitors:
Price Targets
URGN
Urogen Pharma Ltd
62% Upside
XGN
Exagen Inc
120% Upside
301047
Sino Biological Inc
16% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
19% Upside
BIOPOR
Bioporto A/S
274% Upside
COV
Covalon Technologies Ltd
94% Upside
CPRX
Catalyst Pharmaceuticals Inc
54% Upside
KALV
Kalvista Pharmaceuticals Inc
88% Upside

Revenue
Forecast

Revenue Estimate
BioArctic AB

For the last 8 years the compound annual growth rate for BioArctic AB's revenue is 12%. The projected CAGR for the next 3 years is 90%.

12%
Past Growth
90%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BioArctic AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
BioArctic AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOA B's stock price target?
Not Available

BIOA B doesn't have any price targets made by Wall Street professionals.

What is BioArctic AB's Revenue forecast?
Projected CAGR
90%

For the last 8 years the compound annual growth rate for BioArctic AB's revenue is 12%. The projected CAGR for the next 3 years is 90%.

Back to Top